Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;114:2773-2779
Published online before print November 27, 2006, doi: 10.1161/CIRCULATIONAHA.105.582254
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
114/25/2773    most recent
CIRCULATIONAHA.105.582254v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohtani, K.
Right arrow Articles by Sunagawa, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohtani, K.
Right arrow Articles by Sunagawa, K.
Related Collections
Right arrow Restenosis
Right arrow Gene therapy
Right arrow Catheter-based coronary interventions: stents
Right arrow Mechanism of atherosclerosis/growth factors
Right arrow Smooth muscle proliferation and differentiation

(Circulation. 2006;114:2773-2779.)
© 2006 American Heart Association, Inc.


Coronary Heart Disease

Stent-Based Local Delivery of Nuclear Factor-{kappa}B Decoy Attenuates In-Stent Restenosis in Hypercholesterolemic Rabbits

Kisho Ohtani, MD, PhD; Kensuke Egashira, MD, PhD; Kaku Nakano, PhD; Gang Zhao, MD; Kouta Funakoshi, MD; Yoshiko Ihara, MD; Satoshi Kimura, MD; Ryuji Tominaga, MD, PhD; Ryuichi Morishita, MD, PhD; Kenji Sunagawa, MD, PhD

From the Departments of Cardiovascular Medicine (K.O., K.E., K.N., G.Z., Y.I., K.F., K.S.) and Surgery (S.K., R.T.), Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; and Division of Clinical Gene Therapy, Osaka University Medical School, Osaka, Japan (R.M.).

Correspondence to Kensuke Egashira, MD, PhD, Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. E-mail egashira{at}cardiol.med.kyushu-u.ac.jp

Received August 11, 2005; revision received October 10, 2006; accepted October 13, 2006.

Background— Nuclear factor-{kappa}B (NF-{kappa}B) plays a critical role in the vascular response to injury. However, the role of NF-{kappa}B in the mechanism of in-stent restenosis remains unclear. We therefore tested the hypothesis that blockade of NF-{kappa}B by stent-based delivery of a cis-element "decoy" of NF-{kappa}B reduces in-stent neointimal formation.

Methods and Results— Stents were coated with a polymer containing or not containing NF-{kappa}B decoy, which represented a fast-release formulation (<7 days). Bare, polymer-coated, and NF-{kappa}B decoy–eluting stents were implanted in iliac arteries of hypercholesterolemic rabbits. Increased NF-{kappa}B activity was noted at early stages after stenting, which was suppressed by stent-based delivery of NF-{kappa}B decoy. NF-{kappa}B decoy–eluting stents also reduced monocyte infiltration and monocyte chemoattractant protein-1 expression and suppressed CD14 activation on circulating leukocytes. Importantly, NF-{kappa}B decoy–eluting stents attenuated neointimal formation on day 28. There was no evidence of an incomplete healing process (persistent inflammation, hemorrhage, fibrin deposition, impaired endothelial regeneration) at the site of NF-{kappa}B decoy–eluting stents. Transfection of NF-{kappa}B decoy suppressed proliferation of human coronary artery smooth muscle cells in vitro. No systemic adverse effects of NF-{kappa}B decoy were detected.

Conclusions— Stent-based local delivery of NF-{kappa}B decoy reduced in-stent neointimal formation with no evidence of incomplete healing. These data suggest that this strategy may be a practical and promising means for prevention of in-stent restenosis in humans.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Egashira, K. Nakano, K. Ohtani, K. Funakoshi, G. Zhao, Y. Ihara, J.-i. Koga, S. Kimura, R. Tominaga, and K. Sunagawa
Local Delivery of Anti-Monocyte Chemoattractant Protein-1 by Gene-Eluting Stents Attenuates In-Stent Stenosis in Rabbits and Monkeys
Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2563 - 2568.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Hlawaty, A. San Juan, M.-P. Jacob, R. Vranckx, D. Letourneur, and L. J. Feldman
Inhibition of MMP-2 gene expression with small interfering RNA in rabbit vascular smooth muscle cells
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3593 - H3601.
[Abstract] [Full Text] [PDF]